Helicobacter pylori, a gram-negative, microaerophilic, motile, spiral-shape
d bacterium, has been established as the etiologic agent of gastritis and p
eptic ulcers and is a major risk factor for gastric adenocarcinoma and muco
sa-associated lymphoid tissue lymphoma (MALT). The ability of H. pylori to
cause this spectrum of diseases depends on host, bacterial, and environment
al factors. Bacterial factors critical for H. pylori colonization of the ga
stric mucosa include urease, flagella, adhesins, and delta-glutamyltranspep
tidase. Lipopolysaccharide, urease, and vacuolating cytotoxin are among the
factors that allow H. pylori to persist for decades and invoke an intense
inflammatory response, leading to damaged host cells. Genes in the cag path
ogenicity island also contribute to the inflammatory response by initiating
a signal transduction cascade, resulting in interleukin-8 production. Proi
nflammatory cytokines and a Th-1 cytokine response further exacerbates the
inflammation. Products of the enzymes nitric oxide synthase (iNOS) and cycl
ooxygenase may perturb the balance between gastric epithelial cell apoptosi
s (ulcer formation) and proliferation (cancer), The host Th-1 response and
antibodies directed against H. pylori do not eliminate the organism, which
presents challenges to vaccine development. Vaccines that include urease ha
ve shown some promise, but improved adjuvants and animal models should hast
en progress in vaccine research. H. pylori is the most genetically diverse
organism known, and the panmictic population structure may contribute to th
e varying ranges of disease severity produced by different strains. The com
plete genome sequence of two strains of H. pylori has propelled this field
forward, and numerous groups are now using genomic, proteomic, and mutagene
tic approaches to identify new virulence genes. Discovered only in 1982, H.
pylori is now among the most intensely investigated organisms. This review
summarizes recent progress in this rapidly moving field. (C) 2000 Lippinco
tt Williams & Wilkins, Inc.